Results 151 to 160 of about 27,201 (202)

Bone morphogenetic protein 5 as a potential diagnostic and prognostic biomarker in lung adenocarcinoma. [PDF]

Transl Cancer Res
Tian C, Jing X, Luo H, Bai Y.
europepmc   +1 more source

Benchmarking the Ligand-HER2 Interactions Using Machine Learning and Molecular Dynamics Simulations. [PDF]

ACS Omega
Truong DT, Dao QT, Tran TTM, Nguyen NH, Nguyen-Thao MK, Nam NH, Do TMD, Nguyen MT.   +7 more
europepmc   +1 more source

Food Effects, Pharmacokinetic Drug-Drug Interactions, and Clinical Optimization of Oral Anticancer Agents. [PDF]

Pharmaceutics
Assiri AA.
europepmc   +1 more source

Anti-HER2-targeted therapies: effects on human <i>in vitro</i> blood-brain barrier models. [PDF]

Front Drug Deliv
Curtaz CJ, Gebert R, Wöckel A, Meybohm P, Burek M.   +4 more
europepmc   +1 more source

BDDN: bayesian dynamic differential network analysis in cancer proteomics. [PDF]

BMC Bioinformatics
Kim J, Lee D, Park J, Jin IH, Ha MJ.
europepmc   +1 more source

Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR Inhibition. [PDF]

Cell Oncol (Dordr)
van der Noord VE, McLaughlin RP, Karuntu JS, He J, Timmermans AM, Basnet SKC, Long Y, Diab SAH, Tadesse S, Proost N, van Gerwen B, Siteur B, van de Ven M, Pont C, Le Dévédec SE, Martens JWM, Wang S, Zhang Y, van de Water B.   +18 more
europepmc   +1 more source

Epidermal Growth Factor Receptor/KIT-Linked Proliferative Bias in Normal Breast Lobules from Matched Non-Hispanic Black and White Women Is Rapidly Reversible by Receptor Tyrosine Kinase Inhibition. [PDF]

Am J Pathol
Ogony JW, Cruz-Reyes N, Pacheco-Spann L, Arnold A, McLaughlin S, Degnim AC, Winham SJ, Sherman ME, Radisky DC.   +8 more
europepmc   +1 more source

HER2∆16 directs luminal cell identity and estrogen receptor signaling in HER2+ breast cancer. [PDF]

Nat Commun
Proud H, Podleszanski E, Attalla SS, Massey EJ, Taifour T, Eric A, Zuo D, Ling C, Pacis A, Smith HW, Papavasiliou V, Sanguin-Gendreau V, Muller WJ.   +12 more
europepmc   +1 more source

Comprehensive Molecular Docking and Molecular Dynamics Reveal Inhibitors of HER2 L755S, T798I, and T798M based on a Large Database of Curcumin Derivatives. [PDF]

Asian Pac J Cancer Prev
Gusrin MSD, Larasati YA, Utomo RY.
europepmc   +1 more source

Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies. [PDF]

Nat Commun
Desai B, Miti T, Prabhakaran S, Miroshnychenko D, Kumar P, Henry M, Marusyk V, Siqueira NSN, Gatenbee C, Ozakinci H, Bui M, Boyle TA, Scott J, Altrock PM, Pellini B, Haura E, Anderson ARA, Basanta D, Marusyk A.   +18 more
europepmc   +1 more source